脂蛋白(a)残余风险对急性前壁心肌梗死患者急诊PCI术后心肌灌注及预后的影响

张娜娜 ,  李晓燕 ,  张星辉 ,  李柳 ,  王亚洁 ,  史记

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (10) : 877 -881.

PDF (408KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (10) : 877 -881. DOI: 10.12007/j.issn.0258‐4646.2026.10.003
论著

脂蛋白(a)残余风险对急性前壁心肌梗死患者急诊PCI术后心肌灌注及预后的影响

作者信息 +

Effect of lipoprotein (a) residual risk on myocardial perfusion and prognosis after emergency PCI for acute anterior myocardial infarction

Author information +
文章历史 +
PDF (417K)

摘要

目的 评估脂蛋白 (a) [LP (a) ]残余风险对急性前壁心肌梗死患者经皮冠状动脉介入治疗 (PCI) 术后心肌灌注及预后的影响。方法 回顾性分析2021年1月间至2023年1月间于河北医科大学第一医院行急诊PCI的急性前壁心肌梗死住院患者462例的临床资料,所有病例完成规范随访12个月 (共4次)。根据随访低密度脂蛋白胆固醇 (LDL-C)、LP (a) 水平分为双达标组、单达标组、未达标组。观察PCI术后12个月内主要不良心脑血管事件 (MACCE),包括心脏死亡、心肌梗死、心力衰竭、再次血运重建、短暂性脑缺血发作、脑梗死、脑出血。在PCI术后7 d及12个月对患者进行D-SPECT检查心肌灌注情况。结果 双达标组应用PCSK9抑制剂占比较高。Kaplan-Meier生存曲线分析结果显示,双达标组PCI术后12个月内MACCE发生率显著低于单达标组和未达标组 (P = 0.000 4)。PCI术后12个月D-SPECT结果显示,双达标组心肌灌注总积分、异常灌注面积显著优于单达标组及未达标组; 双达标组和单达标组心肌缺血节段数、左室射血分数、左心室舒张末期容积显著优于未达标组 (P < 0.05)。结论 消除LP (a) 残余风险可显著降低PCI术后MACCE发生率,提高心肌灌注。

Abstract

Objective To evaluate the effect of lipoprotein (a) residual risk on myocardial perfusion and prognosis in patients with acute anterior myocardial infarction after percutaneous coronary intervention (PCI). Methods A retrospective analysis was conducted of 462 patients hospitalized at Hebei Medical University First Hospital with post-PCI acute anterior myocardial infarction and who completed regular 12-month follow-up. The patients were assigned to three groups based on their low-density lipoprotein cholesterol and lipoprotein (a) levels at each of the four follow-up visits:the dual-goal achievement group,the single-goal achievement group,and the non-achievement group. There were major post-PCI adverse cardiovascular and cerebrovascular events (MACCEs) within 12 months,including cardiac death,myocardial infarction,heart failure,revascularization,transient ischemic attack,cerebral infarction,and cerebral hemorrhage. Myocardial perfusion was assessed using D-SPECT imaging at seven days and at 12 months,post-PCI. Results The dual-goal achievement group had a higher proportion of PCSK9 inhibitor use. Kaplan-Meier analysis demonstrated a significantly lower 12-month MACCEs rate in the dual-goal achievement group than in the single-goal achievement and non-achievement groups (P = 0.000 4). At the 12-month D-SPECT imaging,the dual-goal achievement group had superior total perfusion deficit scores and reduced abnormal perfusion areas compared with the other groups (P < 0.05). The dual- and single-goal achievement groups had significantly superior improvements in ischemic segment counts,left ventricular ejection fraction,and left ventricular end-diastolic volume than the non-achievement group (P < 0.05). Conclusion Mitigation of lipoprotein (a) residual risk significantly reduced the incidence of MACCEs and enhanced myocardial perfusion in patients with post-PCI acute anterior myocardial infarction.

关键词

脂蛋白 (a) / 急性前壁心肌梗死 / 经皮冠状动脉介入治疗

Key words

lipoprotein (a) / acute anterior myocardial infarction / percutaneous coronary intervention

引用本文

引用格式 ▾
张娜娜,李晓燕,张星辉,李柳,王亚洁,史记. 脂蛋白(a)残余风险对急性前壁心肌梗死患者急诊PCI术后心肌灌注及预后的影响[J]. 中国医科大学学报, 2026, 55(10): 877-881 DOI:10.12007/j.issn.0258‐4646.2026.10.003

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

张大红,戚艳超,刘凌,等. 托莱西单抗对急性前壁心肌梗死急诊冠状动脉支架植入术后患者的疗效与安全性 [J]. 中国医科大学学报,2026,55 (1):48-53. DOI:10.12007/j.issn.0258-4646.2026.01.008.

[2]

Chen R Z,Zhao H J,Yan H B. Long-term management of patients with myocardial infarction:an updated review [J]. Cardiol Discov,2022,2 (4):241-262. DOI:10.1097/cd9.0000000000000073.

[3]

Li R,Dong W G,Wang W X,et al. Addictive effects of Lp (a) and inflammation on cardiovascular risk beyond LDL-C lowering:circulating and genetic evidence from 401,548 adults [J]. Science Bulletin,2025,70 (23):3978-3982. DOI:10.1016/j.scib.2025.10.005.

[4]

于海旭,刘巍. 炎症和胆固醇对他汀类药物治疗患者的残余心血管风险预测价值:来自三项大型临床随机试验的综合分析[J]. 中国医学前沿杂志 (电子版),2023,15 (8):81. DOI:10.3760/cma.j.issn.1674-7372.2023.08.12.

[5]

Ridker P M. Clinician’s guide to reducing inflammation to reduce atherothrombotic risk:JACC review topic of the week [J]. J Am Coll Cardiol,2018,72 (25):3320-3331. DOI:10.1016/j.jacc.2018.06.082.

[6]

李柳,张宁,李含玉,等. 替格瑞洛联合中药治疗微血管心绞痛的效果 [J]. 中国医科大学学报,2025,54 (6):537-541. DOI:10.12007/j.issn.0258-4646.2025.06.010.

[7]

中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中华心血管病杂志编辑委员会. 超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识 [J]. 中华心血管病杂志,2020,48 (4):280-286. DOI:10.3760/cma.j.cn112148-20200121-00036.

[8]

Sabatine M S,Giugliano R P,Keech A C,et al. Evolocumab and clinical outcomes in patients with cardiovascular disease [J]. N Engl J Med,2017,376 (18):1713-1722. DOI:10.1056/NEJMoa1615664.

[9]

蔺晓娟,史苏娜,李琳. 血清PCSK9、Lp (a) 水平对急性心肌梗死者短期发生主要不良心血管事件的预测价值 [J]. 国际检验医学杂志,2026,47 (8):927-931. DOI:10.3969/j.issn.1673-4130.2026.08.006.

[10]

杜明亮,王泊然,惠慧,等. 冠状动脉微循环功能障碍临床研究进展 [J]. 心血管病学进展,2023,44 (8):699-703. DOI:10.16806/j.cnki.issn.1004-3934.2023.08.007.

[11]

中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南 (2019) [J].中华心血管病杂志,2019,47 (10):766-783.DOI:10.3760/cma.j.issn.0253-3758.2019.10.003.

[12]

李柳,李晓燕,高志超,等. 应用瑞加诺生负荷D-SPECT评价定量血流分数在经皮冠状动脉介入治疗中的作用 [J]. 西安交通大学学报 (医学版),2024,45 (3):443-448. DOI:10.7652/jdyxb202403014.

[13]

Kamstrup P R,Tybjaerg-Hansen A,Steffensen R,et al. Genetically elevated lipoprotein (a) and increased risk of myocardial infarction [J]. JAMA,2009,301 (22):2331-2339. DOI:10.1001/jama.2009.801.

[14]

Willeit P,Ridker P M,Nestel P J,et al. Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events:individual patient-data meta-analysis of statin outcome trials [J]. Lancet,2018,392 (10155):1311-1320. DOI:10.1016/S0140-6736(18)31652-0.

[15]

中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南 (2016年修订版) [J]. 中国循环杂志,2016,31 (10):937-950. DOI:10.3969/j.issn.1000-3614.2016.10.001.

[16]

Ray K K,Wright R S,Kallend D,et al. Two phase 3 trials of inclisisiran in patients with elevated LDL cholesterol [J]. N Engl J Med,2020,382 (16):1507-1519. DOI:10.1056/NEJMoa1912387.

基金资助

河北省医学科学研究课题计划(20240314)

AI Summary AI Mindmap
PDF (408KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉